Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

November 28, 2015 10:57 PM ET

Healthcare Equipment and Supplies

Company Overview of TransMedics, Inc.

Company Overview

TransMedics, Inc. develops living organ transplant systems. It offers TransMedics Organ Care System, a portable warm blood perfusion system, designed to maintain organs in a warm and functioning state outside the human body during transport from organ donor to recipient. The company’s products are used in heart, lung, liver, and kidney transplants. It serves hospitals and clinicians, patients and families, donor organizations, and insurers and payors. The company markets and sells its products in the United States, the European Union, Asia, and the Middle East. TransMedics was founded in 1998 and is headquartered in Andover, Massachusetts.

200 Minuteman Road

Suite 302

Andover, MA 01810

United States

Founded in 1998

93 Employees





Key Executives for TransMedics, Inc.

Founder, Chief Executive Officer, President and Director
Age: 47
Chief Financial Officer
Vice President of Operations
Age: 52
Chief Medical Officer
Age: 46
Director of IP & In-house Counsel
Compensation as of Fiscal Year 2015.

TransMedics, Inc. Key Developments

TransMedics, Inc. Presents at Canaccord Genuity 2015 Medical Technology & Diagnostics Forum, Nov-19-2015 03:00 PM

TransMedics, Inc. Presents at Canaccord Genuity 2015 Medical Technology & Diagnostics Forum, Nov-19-2015 03:00 PM. Venue: Westin Grand Central, New York, New York, United States.

TransMedics, Inc. Announces Final Results of The PROCEED II Heart FDA Pivotal Trial at ISHLT

TransMedics, Inc. announced that the PROCEED II heart transplant Food and Drug Administration pivotal trial results using the Organ Care System - Heart platform were announced on Saturday, April 12, 2014 at the International Society for Heart and Lung Transplantation 34th Annual Meeting and Scientific Sessions in San Diego, Calif. The OCS Heart PROCEED II FDA pivotal trial met its success criteria for both the primary effectiveness and safety endpoints by demonstrating that the OCS is as safe and effective as the current standard of care (SOC) in preserving standard donor hearts for transplantation. These results were achieved despite the OCS arm having significantly longer total cross clamp time as compared to SOC. In addition, the data from PROCEED II Trial demonstrated that circulating lactate level of the OCS perfusion could be a useful parameter to evaluate donor hearts status ex-vivo.

Similar Private Companies By Industry

Company Name Region
GrantAdler Corporation United States
DesChutes Medical Products, Inc. United States
Trex Medical Corporation United States
Peca Labs, Inc. United States
Digit-Pro, Inc. United States

Recent Private Companies Transactions

Private Placement
September 11, 2015
Private Placement
May 29, 2015

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact TransMedics, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at